Poseltinib Uses, Dosage, Side Effects and more
Poseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis).
| Trade Name | Poseltinib |
| Generic | Poseltinib |
| Poseltinib Other Names | Poseltinib |
| Type | |
| Formula | C26H26N6O3 |
| Weight | Average: 470.533 Monoisotopic: 470.206638721 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
